MDT

87.66

-0.88%↓

VEEV

280.9

-1.16%↓

A

119.22

-1.87%↓

WBA

11.53

+0.52%↑

HQY

101.41

-0.54%↓

MDT

87.66

-0.88%↓

VEEV

280.9

-1.16%↓

A

119.22

-1.87%↓

WBA

11.53

+0.52%↑

HQY

101.41

-0.54%↓

MDT

87.66

-0.88%↓

VEEV

280.9

-1.16%↓

A

119.22

-1.87%↓

WBA

11.53

+0.52%↑

HQY

101.41

-0.54%↓

MDT

87.66

-0.88%↓

VEEV

280.9

-1.16%↓

A

119.22

-1.87%↓

WBA

11.53

+0.52%↑

HQY

101.41

-0.54%↓

MDT

87.66

-0.88%↓

VEEV

280.9

-1.16%↓

A

119.22

-1.87%↓

WBA

11.53

+0.52%↑

HQY

101.41

-0.54%↓

Search

Avanos Medical Inc

Suletud

SektorTervishoid

11.85 -3.66

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

11.65

Max

12.32

Põhinäitajad

By Trading Economics

Sissetulek

5.8M

6.6M

Müük

-12M

168M

P/E

Sektori keskmine

33.255

40.527

Aktsiakasum

0.141

Kasumimarginaal

3.94

Töötajad

2,227

EBITDA

428M

21M

Soovitused

By TipRanks

Soovitused

Neutraalne

12 kuu keskmine prognoos

+13.36% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

30. juuli 2025

Turustatistika

By TradingEconomics

Turukapital

-198M

566M

Eelmine avamishind

15.51

Eelmine sulgemishind

11.85

Uudiste sentiment

By Acuity

50%

50%

113 / 375 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bullish Evidence

Avanos Medical Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

6. juuli 2025, 23:55 UTC

Market Talk

Gold Edges Lower on Possible Position Adjustments -- Market Talk

6. juuli 2025, 22:35 UTC

Omandamised, ülevõtmised, äriostud

South32 Expects to Complete Transaction in Late 2025

6. juuli 2025, 22:35 UTC

Omandamised, ülevõtmised, äriostud

South32: CoreX to Make Future Cash Payments of Up to US$100 Million for Cerro Matoso

6. juuli 2025, 22:34 UTC

Omandamised, ülevõtmised, äriostud

South32 Agrees to Sell Cerro Matoso Nickel Operation to Unit of CoreX Holding

5. juuli 2025, 04:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

4. juuli 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

4. juuli 2025, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

4. juuli 2025, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

4. juuli 2025, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

4. juuli 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

4. juuli 2025, 16:20 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

4. juuli 2025, 16:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

4. juuli 2025, 16:20 UTC

Market Talk

Health Care Roundup: Market Talk

4. juuli 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

4. juuli 2025, 15:57 UTC

Market Talk

Base Metal Prices Fall in Thin, Risk-off Trading -- Market Talk

4. juuli 2025, 15:49 UTC

Market Talk

Gold Futures Set to End Week Flat After Mixed Jobs Report -- Market Talk

4. juuli 2025, 15:49 UTC

Omandamised, ülevõtmised, äriostud

Credit Agricole: Deal Will Have a Negative Impact of Approximately 30 Basis Points on the Fully-Loaded CET1 Ratio

4. juuli 2025, 15:49 UTC

Omandamised, ülevõtmised, äriostud

Credit Agricole: Transaction Is Consistent With Targets in Terms of Return of Investment, Return on Tangible Equity

4. juuli 2025, 15:49 UTC

Omandamised, ülevõtmised, äriostud

Credit Agricole Received All Required Authorizations

4. juuli 2025, 15:48 UTC

Omandamised, ülevõtmised, äriostud

Credit Agricole: CACEIS and Santander Are Maintaining Their Long-Term Partnership

4. juuli 2025, 15:47 UTC

Omandamised, ülevõtmised, äriostud

Credit Agricole: Agreement Was Announced on Dec. 19

4. juuli 2025, 15:47 UTC

Omandamised, ülevõtmised, äriostud

Credit Agricole Now Controls 100% of the Share Capital of CACEIS

4. juuli 2025, 15:46 UTC

Omandamised, ülevõtmised, äriostud

Credit Agricole Completes Acquisition of Santander's 30.5% Stake in CACEIS

4. juuli 2025, 14:30 UTC

Omandamised, ülevõtmised, äriostud

Rocky Shore Closes Hemlo Area Claims Sale to Barrick Mining Unit for C$975,000 Cash

4. juuli 2025, 13:53 UTC

Market Talk

Polish Zloty Faces Hit From Prospect of Further Rate Cuts -- Market Talk

4. juuli 2025, 13:41 UTC

Market Talk

Japanese Yen Could Receive Boost From Increased Rate-Hike Bets -- Market Talk

4. juuli 2025, 13:41 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

4. juuli 2025, 13:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

4. juuli 2025, 12:37 UTC

Market Talk

Fund Manager Roundup: U.S. Treasurys in Focus Amid Rising Debt

4. juuli 2025, 12:37 UTC

Market Talk

Fund Manager Roundup: U.S. Treasurys in Focus -2-

Võrdlus sarnastega

Hinnamuutus

Avanos Medical Inc Prognoos

Hinnasiht

By TipRanks

13.36% tõus

12 kuu keskmine prognoos

Keskmine 14 USD  13.36%

Kõrge 14 USD

Madal 14 USD

Põhineb 2 Wall Streeti analüütiku instrumendi Avanos Medical Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

2 ratings

0

Osta

2

Hoia

0

Müü

Tehniline skoor

By Trading Central

12.28 / 12.71Toetus ja vastupanu

Lühikene perspektiiv

Very Strong Bullish Evidence

Keskpikk perspektiiv

Bullish Evidence

Pikk perspektiiv

No Evidence

Sentiment

By Acuity

113 / 375 Pingereas Tervishoid

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Avanos Medical Inc

Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.